2022 NADDI National Healthcare Facility Rx Diversion Summit

We're sorry, but all tickets sales have ended because the event is expired.
  • 2022 NADDI National Healthcare Facility Rx Diversion Summit
    April 25, 2022
    8:00 am - 5:00 pm
  • 2022 NADDI National Healthcare Facility Rx Diversion Summit
    April 26, 2022
    8:00 am - 5:00 pm

“The scope and frequency of drug diversion is almost impossible to grasp, due in large part to how diversion cases are addressed. A facility that identifies a diversion problem might bring in any combination of players, from private investigators and local law enforcement to state accreditation boards or the Drug Enforcement Administration (DEA). There is no overarching agency or organization that records every instance of drug diversion in the United States.”
Lilly Chapa – The Dirty Little Secret of Drug Diversion

NADDI National Healthcare Facility Rx Diversion Summit – Registration open Monday, February 7th
April 25-26, 2022

Sheraton Raleigh Downtown 
421 South Salisbury Street
Raleigh, NC 27601

Attendees Invited:
Medication Safety and Patient Safety Officers
Risk Management and Quality Managers
Medication Safety Committees
Nurses
Pharmacists
Pharmacy Technicians
Physicians
Hospital Security
State Regulatory Agents

Law Enforcement

The safety and wellbeing of our attendees and colleagues is always a top priority. The Sheraton and NADDI will follow all state and CDC guidelines during the conference.

GOLD Sponsoe – Invistics
GOLD Sponsor – Kit Check
GOLD Sponsor – Protenus
GOLD SPONSOR – Titan Group DEA Compliance Experts

SILVER Sponsor – Codonics
SILVER Sponsor – International Medical Industries, INC (IMI)
SILVER Sponsor – Imprivata


For information about sponsorship and exhibiting, contact Charlie Cichon at ccichon@naddi.org

Sunday, April 24, 2022
4:00pm Early Registration – Oak Forest Ballroom Foyer
5:00pm Welcome Reception – Esplanade

As topics and speakers are confirmed, they will be added to the agenda.

Monday, April 25, 2022
7:30am – Coffee Service / Exhibits Open
8:30 am Welcoming Remarks
Morning General Session

Drug Diversion: A Hidden Epidemic in Healthcare
Sandy Still, PharmD
Pharmacy Coordinator – Medication Safety Use & Policy
Medical University of South Carolina

Hospital Diversion Cases in Canada
Frank Breve, PharmD, MBA, CCP
Clinical Pharmacist Consultant
Mid Atlantic PharmaTech Consultants, LLC

Identifying and Assisting the Impaired Healthcare Worker
Angela Livingood, PharmD, MHA
Diversion Specialist
Novant Health (NC)

Networking Luncheon provided

Afternoon General Session

Healthcare System Centralized Drug Diversion Services
Establishing a Dedicated, Centralized Team in the Organization for Multi-Site Diversion prevention and Detection

Danielle Neal, PharmD, MBA
Director, Drug Diversion Prevention & Controlled Substance Compliance
Atrium Health Wake Forest Baptist

Leah Mitchell, PharmD, MBA
Drug Diversion Pharmacist
Department of Pharmacy
Atrium Health Wake Forest Baptist

National Drug Diversion Prevention Startegy for a Large Healthcare System – Comprehensive Approach at Ascension to prevent drug diversion and what we are doing when identified
Katie Shell, PharmD, CpH

Area Manager Clinical Operations – Texas Market
Pharmacy Clinical Operations
Ascension

Enhanced Analytics to Mitigate Diversion Risk
Jason North, PharmD, MBA

Pharmacy Director
Great Plains Health (NE)

5:00pm Closing Remarks

Dinner on your own

As topics and speakers are confirmed, they will be added to the agenda.

Tuesday, April 26, 2022
8:00am – Coffee Service / Exhibits Open
Morning General Session

Education – Diversion Prevention’s Backbone
Evan Frasure, PharmD, BCPS
Director, Controlled Substance Diversion Prevention
Duke University Health System

Education is the backbone to any successful diversion prevention program.  In this presentation you will learn how to effectively provide education to team members at your institution.  We will discuss, content, methods, considerations and how to know your message is being received.  By the end you will be able to confidently implement, improve, or maintain your approach to diversion prevention implementation at your institution.

Drug Tampering in Healthcare Facilities – Case Studies from Recent FDA Office of Tampering Investigations
Common Red Flags Missed by Facilities
Tips for Prevention
Tampering Response Guide

Joseph McCulley, Special Agent
FDA Office of Criminal Investigations

Case Study: Leveraging Resources for Identifying Diversion in Radiology
From a single needle in a bathroom to a comprehensive case and diversion confession.
Danielle Neal, PharmD, MBA
Director, Drug Diversion Prevention & Controlled Substance Compliance
Atrium Health Wake Forest Baptist

Leah Mitchell, PharmD, MBA
Drug Diversion Pharmacist
Department of Pharmacy
Atrium Health Wake Forest Baptist

Networking Luncheon provided

Afternoon General Session

Panel Discussion
This panel will facilitate controlled substance diversion table top exercises — simulations presented for audience participation in practicing response efforts, as well as generating lessons learned.

Raymond A. Shelton
HIPAA Security Officer
Assurance and Compliance Services
Mount Sinai Health System

Billy Sin, PharmD, MBA, BCPS
Associate Director of Pharmacy
Mount Sinai Beth Israel

Alissa W Hui
Manager, Pharmacy
Mount Sinai Beth Israel

Laura A Butler, MSN, RN, NEA-BC, OCN
Director of Nursing Professional Practice-MSH Nursing
Mount Sinai Hospital

Many Eyes Make Light Work

Sacha Pollard Deloney, PharmD, MBA
System Pharmacy Director
Safety, Quality and Educational Programs
Novant Health Pharmacy Administration

Barbara Kirkaldy
Pharmacy Regulatory Specialist DEA / BOP
Novant Health Pharmacy Administration

Angela Livingood, PharmD, MHA
Diversion Specialist
Novant Health (NC)

4:30pm Closing Remarks

Don’t Forget!

Make sure you make your room reservations before the March 22, 2022 cut-off date to obtain NADDI pricing.

NADDI Conference Room Rate $139.00 single/double

To Make your room reservations CLICK HERE

If you need additional assistance, please contact Marriott reservations at 1-800-325-3535 and mention “NADDI Healthcare Conference” – The cut-off date to receive the conference rate is March 22, 2022.

Cancellation/Refund Policy

All registrations are subject to NADDI’s Registration Deadline and Refund Policy.

Cancellation requests for any NADDI Conference Registration must be made in writing by emailing info@naddi.org

Cancellations more than 30 days before the event will be charged a cancellation fee of $100.00 (or full registration amount, whichever is less) will be deducted from the refund. All refunds will be made by check and will be sent to the original payer on file.

Cancellations less than 30 days before the event will not be eligible for refund.

Registrants wishing to cancel may instead transfer registration to someone else without penalty if they send a written request, no later than 24 hours prior to the conference, with the replacement person’s name.

Credit vouchers may be offered in the event of a medical emergency, or should the program be suspended or shortened due to conditions or circumstances beyond NADDI’s control, including but not limited to any cancellations/notifications related to the COVID-19 pandemic.

All cancellations will be reviewed by the NADDI Board of Directors or its Designee, who in turn will recommend the appropriate refund and/or action.

National Association of Drug Diversion Investigators Federal Tax ID: 52-1660752 / DUNS Number: 073539913

Copyright © 2023 - NADDI. All Rights Reserved. Privacy Policy / Trademark Policy / Copyright Policy / Refund Policy

Log in with your credentials

or    

Forgot your details?

Create Account